Browse by Research Center
Number of items: 6. BBecker, MA and Ibrahim, YH and Oh, AS and Fagan, DH and Byron, SA and Sarver, AL and Lee, AV and Shaw, LM and Fan, C and Perou, CM and Yee, D (2016) Insulin receptor substrate adaptor proteins mediate prognostic gene expression profiles in breast cancer. PLoS ONE, 11 (3). HHe, M and Zhou, Z and Shah, AA and Hong, Y and Chen, Q and Wan, Y (2016) New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics. Cell Division, 11 (1). MMehta, K and Appleman, L and Wang, H and Tarhini, AA and Parikh, RA (2016) Annual hospital volume of high dose interleukin-2 and inpatient mortality in melanoma and renal cell carcinoma patients. PLoS ONE, 11 (1). RRadomski, M and Zeh, HJ and Edington, HD and Pingpank, JF and Butterfield, LH and Whiteside, TL and Wieckowski, E and Bartlett, DL and Kalinski, P (2016) Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer. Journal for ImmunoTherapy of Cancer, 4 (1). Retseck, J and VanderWeele, R and Lin, HM and Lin, Y and Butterfield, LH and Tarhini, AA (2016) Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab. Journal for ImmunoTherapy of Cancer, 4 (1). YYuan, J and Hegde, PS and Clynes, R and Foukas, PG and Harari, A and Kleen, TO and Kvistborg, P and Maccalli, C and Maecker, HT and Page, DB and Robins, H and Song, W and Stack, EC and Wang, E and Whiteside, TL and Zhao, Y and Zwierzina, H and Butterfield, LH and Fox, BA (2016) Novel technologies and emerging biomarkers for personalized cancer immunotherapy. Journal for ImmunoTherapy of Cancer, 4 (1). |